Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Courses
    • Degree programs
    • Workshops
  • About
    • Racism is a public health issue.
    • Our Principles
    • Faculty
    • Senior Management Team
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

GBD 2019 Cause and Risk Summaries


Global Burden of Disease 2019 disease, injury, and impairment summaries

These two-page summaries offer a concise overview of causes, impairments, and risk factors modeled in GBD and the health loss related to them. The summaries include a summary results statement; a definition of the disease, injury, impairment, or risk; and a brief listing of modeling updates in GBD 2019 compared to previous GBD rounds. Tables and figures display metrics for each topic. Please use the menus below to select your topic of interest. To learn more about what the summaries include, please visit these pages: 

  • Learn more about GBD 2019 Disease, Injury, and Impairment Summaries
  • Learn more about GBD 2019 Risk Factor Summaries
Displaying 1 - 10 of 454

Acne vulgaris — Level 3 cause

Summary Globally, acne vulgaris was responsible for 4·96 million (95% UI 2·98–7·85) DALYs in 2019. Of these, 3·52 million (2·11–5·64) DALYs occurred in those ages 15–49 years old. Definition Acne vulgaris (or acne) is a chronic inflammatory disease of the pilosebaceous unit associated with an...Read more

Acute glomerulonephritis — Level 3 cause

Summary 722 000 cases (95% UI 595 000–878 000) of acute glomerulonephritis occurred in 2019, resulting in 10 500 deaths (7200–12 200) and 307 000 global DALYs (204 000–363 000). Definition This Level 3 cause incorporates death and disability resulting from acute episodes of inflammation and injury...Read more

Acute hepatitis A — Level 4 cause

Summary Acute hepatitis A resulted in 2·35 million (95% UI 1·70–3·09) global DALYs in 2019 and was responsible for 53·9% (42·9–63·6) of acute hepatitis DALYs. Definition Hepatitis A is a viral infection that affects the liver. It is transmitted by faeco-oral route. Total sources Incidence 0...Read more

Acute hepatitis B — Level 4 cause

Summary Acute hepatitis B resulted in 1·61 million (95% UI 1·17–2·21) global DALYs in 2019 and was responsible for 37·2% (27·8–47·4) of acute hepatitis DALYs. Definition Hepatitis B is a viral infection of the liver. It can be transmitted during medical procedures, through unsafe injecting,...Read more

Acute hepatitis C — Level 4 cause

Summary Acute hepatitis C resulted in 253 000 global DALYs (95% UI 145 000–375 000) in 2019 and was responsible for 5·8% (3·4–8·8) of acute hepatitis DALYs. Definition Hepatitis C is a viral infection of the liver. It is transmitted through injecting needles and during medical procedures. Total...Read more

Acute hepatitis E — Level 4 cause

Summary Acute hepatitis E resulted in 131 000 global DALYs (95% UI 84 600–191 000) in 2019 and was responsible for 3·0% (2·1–4·0) of acute hepatitis DALYs. Definition Hepatitis E is a viral infection that affects the liver. It is transmitted by faeco-oral route. Total sources Incidence 0 Prevalence...Read more

Acute hepatitis — Level 3 cause

Summary Acute hepatitis resulted in 4·35 million (95% UI 3·57–5·22) global DALYs in 2019. Acute hepatitis A, B, C, and E contributed 53·9% (42·9–63·6), 37·2% (27·8–47·4), 5·8% (3·4–8·8), and 3·0% (2·1–4·0) to DALYs for the acute hepatitis parent, respectively. Definition Hepatitis is a viral...Read more

Acute lymphoid leukemia — Level 4 cause

Summary There were 153 000 incident cases (95% UI 129 000–171 000), 47 600 deaths (39 400–53 000), and 2·66 million (2·19–3·01) DALYs due to acute lymphoid leukaemia globally in 2019. Definition This cause includes death and disability resulting from invasive neoplasms of the blood and bone marrow...Read more

Acute myeloid leukemia — Level 4 cause

Summary There were 124 000 incident cases (95% UI 109 000–136 000), 94 100 deaths (82 600–101 000), and 3·06 million (2·77–3·37) DALYs due to acute myeloid leukaemia globally in 2019. Definition This cause includes death and disability resulting from invasive neoplasms of the blood and bone marrow...Read more

Adverse effects of medical treatment — Level 3 cause

Summary Adverse effects of medical treatment were responsible for 106 000 deaths (95% UI 89 100–117 000) in 2019. The age-standardised mortality rate decreased from 1·5 per 100 000 (1·3–1·7) in 2010 to 1·4 per 100 000 (1·1–1·5) in 2019. Definition Death or short-term or long-term disability...Read more

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Results

  • GBD Results Tool
  • Data Visualizations
  • Country Profiles
  • GBD 2019 Cause and Risk Summaries
  • US Health
  • Policy Reports
  • Research Articles
  • Infographics
  • Topics
  • Data & Tools

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Courses
    • Degree programs
    • Workshops
  • About
    • Racism is a public health issue.
    • Our Principles
    • Faculty
    • Senior Management Team
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • Local Burden of Disease
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts